Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03043963 · ClinicalTrials.gov registry record · NA

Mechanisms Underlying the Blood Pressure Lowering Effect of Sleep

A NA study of Hypertension, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT03043963 is a NA study of Hypertension that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 270 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03043963, a NA study of Hypertension, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to learn about the influence of two different behavioral interventions (lasting 8 weeks) involving sleep for lowering blood pressure, and to study the mechanisms involved. There is research evidence that healthy sleep promotes heart-health and may decrease blood pressure, and that sensitivity to insufficient or disrupted sleep may be influenced by sex. This research will compare two interventions that are each designed to improve sleep health, and will investigate sex differences in response. The project includes 3 in-hospital stays with biological measurements to evaluate the underlying mechanisms associated with the effectiveness of two different blood pressure lowering behavioral interventions.

Conditions Studied

Interventions

  • BEHAVIORAL Sleep Extension
  • BEHAVIORAL Sleep Timing

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2017-02-10
Est. Completion 2022-09-21
Phase NA

What the Registry Record Tells You About NCT03043963

The ClinicalTrials.gov registry entry for NCT03043963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Sleep Extension is the first listed.

NCT03043963 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03043963 about?

NCT03043963 is a clinical study titled "Mechanisms Underlying the Blood Pressure Lowering Effect of Sleep". The main purpose of this study is to learn about the influence of two different behavioral interventions (lasting 8 weeks) involving sleep for lowering blood pressure, and to study the mechanisms involved. There is research evidence that healthy sleep promotes heart-health and may decrease blood pre...

What is the current status of trial NCT03043963?

This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2017-02-10. Estimated completion is 2022-09-21.

What conditions does trial NCT03043963 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT03043963?

The interventions under investigation include: Sleep Extension (BEHAVIORAL), Sleep Timing (BEHAVIORAL).

Who is sponsoring clinical trial NCT03043963?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03043963 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.